1Sipahi I,Debarme SM,Rowland DY,et al.Angiotensin-receptor blockade and risk of cancer:meta-analysis of randomised controlled trials[J].Lancet Oncol,2010,11(7):627-636.
2Chehl N,Gong Q,Chipitsyna G,et al.Angiotensin II regulates the expression ofmonocyte chemoattractant protein-1 in pancreatic cancer cells[J].J Gastrointest Surg,2009,13(12):2189-2200.
3Miyajima A,Kikuchi E,Kosaka T,et al.Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in urogenital cancer[J].Rev Recent Clin Trials,2009,4(2):75-78.
4Anandanadesan R,Gong Q,Chipitsyna G,et al.Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK 1/2 signaling[J].J Gastrointest Surg,2008,12(1):57-66.
5Kosaka T,Miyajima A,Takayama E,et al.Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer[J].Prostate,2007,67(1):41-49.